Cancer represents the second cause of death in prepubertal children and adolescents, although it is currently associated with an overall sur-vival rate of 80%-85%. The annual incidence rate is 186.6 per 1 million children and adolescents aged up to 19 years. Both disease and treatment options are associated with life-altering, long-term effects that require monitoring. Infertility is a common issue, and as such, fertility preservation represents an essential part in the management of young patients with cancer who are at risk of premature gonadal failure. This review deals with the up-to-date available data on fertility risk assessment and preservation strategies that should be addressed prior to antineoplastic therapy in this vulnerable subgroup of cancer patients.
CITATION STYLE
Zavras, N., Ssiristatidis, C., Ssiatelis, A., & Koumarianou, A. (2016, June 28). Fertility risk assessment and preservation in male and female prepubertal and adolescent cancer patients. Clinical Medicine Insights: Oncology. Libertas Academica Ltd. https://doi.org/10.4137/CMO.S32811
Mendeley helps you to discover research relevant for your work.